Israeli researcher finds out how deadly skin cancer passes the blood-brain barrier and tests a treatment that delays spread of the metastases by up to 80%.
The research is of critical importance, as melanoma metastases are particularly aggressive. Patients have a “poor prognosis of 15 months following surgery, radiation and chemotherapy,” Said Tel Aviv University cancer biologist Prof. Ronit Satchi-Fainaro.
The treatment, when applied immediately after surgery, prevented the metastases from penetrating the brain. “I believe that the treatment is suitable for the clinic as a preventative measure,” Satchi-Fainaro said. Best of all, the antibody and the synthetic molecule already have been tested on humans and are considered safe. They are used to treat sclerosis, diabetes, liver fibrosis and cardiovascular diseases.
Amazing!
Source/Photo: Israel21C